• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.17% Nasdaq Up0.08%

    More On MRK.DE



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Merck KGaA (MRK.DE)

    81.14 Down 0.93(1.13%) 9:16AM EDT
    ProfileGet Profile for:
    Merck KGaA
    Frankfurter Strasse 250
    Darmstadt, 64293
    Germany - Map
    Phone: 49 6151 72 0
    Fax: 49 6151 72 5577
    Website: http://www.merckgroup.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:40,339

    Business Summary 

    Merck Kommanditgesellschaft auf Aktien discovers, develops, manufactures, and markets pharmaceutical and chemical products worldwide. It operates through three segments: Healthcare, Life Science, and Performance Materials. The company provides pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis, infertility and growth disorders, and cardiovascular and metabolic diseases; fertility drugs for every stage of the reproductive cycle; allergen products to diagnose and treat type 1 allergies, such as hay fever or allergic asthma; and biosimilars focusing on oncology and inflammatory disorders. It also manufactures and markets over-the-counter pharmaceuticals and food supplements under the Neurobion, Bion, Seven Seas, Nasivin, Femibion, Dolo-Neurobion, Floratil, Sangobion, Vigantoletten, Apaisyl, and Kytta brand names. In addition, the company offers life science tools and technologies for use in the research, development, and manufacture of biotechnological and pharmaceutical drug therapies, as well as in research and application laboratories. Further, it provides performance chemicals for applications in the fields, such as consumer electronics, lighting, coatings, printing technology, paints, plastics, and cosmetics. Merck Kommanditgesellschaft auf Aktien was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Merck KGaA

    Key Executives 
    Dr. Karl-Ludwig Kley , 65
    Chairman of Exec. Board
    Dr. Stefan Oschmann , 59
    Vice Chairman of Exec. Board, Deputy Chief Exec. and Chairman of Corp. Responsibility Committee
    Dr. Marcus Kuhnert , 48
    Chief Financial Officer and Member of Exec. Board
    Dr. Bernd Reckmann , 61
    Chief Exec. Officer of Life Science & Performance Materials and Member of Exec. Board
    Dr. Kai Beckmann , 51
    Chief Admin. Officer and Member of Exec. Board
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.